The selective personalized radioimmunotherapy for locally advanced NSCLC trial (SPRINT).

Nitin Ohri,Haiying Cheng,Shruti Jolly,Shirish M. Gadgeel,Benjamin T. Cooper,Elaine Shum,Balazs Halmos

The selective personalized radioimmunotherapy for locally advanced NSCLC trial (SPRINT).

2019

Nitin Ohri
Haiying Cheng
Shruti Jolly
Shirish M. Gadgeel
Benjamin T. Cooper
Elaine Shum
Balazs Halmos

TPS8571Background: Concurrent chemoradiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC) can cause significant toxicities, and disease recurrence after treatment is common. We pre...

Keywords:

Chemoradiotherapy
Radioimmunotherapy
Sprint
Lung cancer
Disease
Oncology
Pathology
Medicine
Internal medicine
locally advanced
concurrent chemoradiotherapy
after treatment
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations